Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2775367
Reference Type
Journal Article
Title
Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets
Author(s)
Gupta, VD; Stewart, KR
Year
1987
Is Peer Reviewed?
Yes
Journal
American Journal of Hospital Pharmacy
ISSN:
0002-9289
Report Number
IPA/87/729106
Volume
J
Issue
REF 3
Page Numbers
360-361
Language
English
Abstract
IPA COPYRIGHT: ASHP The stability of an oral solution or suspension of propranolol hydrochloride (Inderal; I), prepared from either I injection or oral tablet, was studied. The suspension was prepared by crushing 6 tablets of I, 20 mg each, and mixing with 240 ml of a simple syrup containing sucrose (II), 600 mg/ml. The solution was prepared by diluting 50 ml of I injection, 1 mg/ml with the syrup to yield a total volume of 100 ml. After storage at 25DGC, each formulation was assayed at intervals up to 238 days by high performance liquid chromatography. The results indicate that both preparations retained almost original potency after 238 days of storage at room temperature. The clarity of the solutions did not change, and changes in the pH values were negligible. There were no visible signs of any fungus growth; this was expected since the syrup contained sodium benzoate as the preservative. It was concluded that oral liquid dosage forms of I can be prepared by suspending triturated tablets in or mixing an injectable preparation of the drug with a simple syrup of II, 600 mg/ml.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity